Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
DIVISLAB Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and improving ROE
High and improving operating margin
Moderate revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
DIVISLAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
DIVISLAB Bulk, Block & Insider Trades
DIVISLAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Bonus(1 new shares for 1 existing shares) Ex-date: 23rd Sep 2015 Announced on: 8th Aug 2015
Bonus(1 new shares for 1 existing shares) Ex-date: 30th Jul 2009 Announced on: 6th Jun 2009
Stock split(1 : 5)Nominal value change from Rs. 10 to Rs. 2 Ex-date: 3rd Aug 2007 Announced on: 23rd May 2007
Company Profile
Divis Laboratories Limited is an India-based company, which is engaged in pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextrome... Read More
Key personnel
Dr. Ramesh B. Venkata NimmagaddaD
Non-Executive Independent Chairman of the Board
Dr. Kiran Satchandra Divi, Ph.D.D
Chief Executive Officer, Whole-Time Director
Mr. Venkatesa Perumallu Pasumarthy
Chief Financial Officer
Mr. Manoranjan Jasti
Chief Information Officer
Mr. Meka Satish Choudhury
Compliance Officer, Company Secretary
Dr. Murali Krishna Pr Divi, Ph.D.D
Managing Director, Executive Director
Ms. Nilima Prasad DiviD
Whole-Time Director - (Commercial)
Shri. Nimmagadda Venkata RamanaD
Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Divis Laboratories Ltd.?
The current share price of Divis Laboratories Ltd. is ₹ 6,616.68 as of 09 Jan 2026.
What is the PE ratio of Divis Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Divis Laboratories Ltd. is 70.69 as of the latest financial data.
What is the ROE and ROCE of Divis Laboratories Ltd.?
Divis Laboratories Ltd. has a Return on Equity (ROE) of 17.06% and a Return on Capital Employed (ROCE) of 19.26% as per the latest financial reports.
What is the market cap of Divis Laboratories Ltd.?
The market capitalization of Divis Laboratories Ltd. stands at ₹ 1,75,652.00 Cr.
What is the dividend yield of Divis Laboratories Ltd.?
The dividend yield of Divis Laboratories Ltd. is 0.45% based on the current market price.
What is the RSI of Divis Laboratories Ltd.?
The Relative Strength Index (RSI) of Divis Laboratories Ltd. is 60.98.
What is the FII and DII holding in Divis Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 20.08% and Domestic Institutional Investors (DII) hold 18.69% of Divis Laboratories Ltd. shares.
What sector does Divis Laboratories Ltd. belong to?
Divis Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Divis Laboratories Ltd. stock?
The beta of Divis Laboratories Ltd. stock is 0.83, indicating its volatility relative to the broader market.
